US Map / Alabama
State AL

Clinical Trials in Alabama

Recruiting clinical trials with at least one study location in Alabama. Data updated daily from ClinicalTrials.gov.

Total Trials
178
Recruiting Now
178
← Back to US Map
Top Conditions in Alabama
Malignant Solid Neoplasm (4)Obesity (4)Sickle Cell Disease (3)Cystic Fibrosis (3)Atopic Dermatitis (3)Sjogren Syndrome (2)Acute Respiratory Distress Syndrome (2)Malignant Neoplasm (2)Weight Loss (2)Convulsion, Non-Epileptic (2)Atrial Fibrillation (AF) (2)Cardiovascular Diseases (2)
NCT03907046 Phase 3
Recruiting
Anticoagulation in ICH Survivors for Stroke Prevention and Recovery
Condition
Intracerebral Hemorrhage
Enrollment
700 pts
Location
United States
Sponsor
Yale University
View Trial →
NCT03911388 Phase 1
Recruiting
HSV G207 in Children With Recurrent or Refractory Cerebellar Brain Tumors
Condition
Neoplasms, Brain
Enrollment
24 pts
Location
United States
Sponsor
M.D. Anderson Cancer Center
View Trial →
NCT06625437 N/A
Recruiting
ACT for HIV-Positive Men
Condition
Stress
Enrollment
24 pts
Location
United States
Sponsor
University of Alabama at Birmi
View Trial →
NCT05384145 N/A
Recruiting
Implementation Trial to Evaluate a Population Health Combination Intervention to...
Condition
HIV
Enrollment
80 pts
Location
United States
Sponsor
University of Alabama at Birmi
View Trial →
NCT04592445 N/A
Recruiting
Endovascular Ablation of the Right Greater Splanchnic Nerve in Subjects Having H...
Condition
Heart Failure With Preserved Ejection Fraction (HFpEF
Enrollment
150 pts
Location
United States
Sponsor
Axon Therapies, Inc.
View Trial →
NCT06317662 Phase 2
Recruiting
Testing the Addition of the Anti-cancer Drug Venetoclax and/or the Anti-cancer I...
Condition
Acute Leukemia of Ambiguous Lineage
Enrollment
153 pts
Location
United States, Puerto Rico
Sponsor
National Cancer Institute (NCI
View Trial →
NCT05268042 N/A
Recruiting
Moderately Carbohydrate-restricted Diet to Treat NAFLD in Adolescents
Condition
Non-Alcoholic Fatty Liver Disease
Enrollment
80 pts
Location
United States
Sponsor
University of Alabama at Birmi
View Trial →
NCT05958654 N/A
Recruiting
DETECT-RPC Universal EM Screening
Condition
Elder Abuse
Enrollment
43 pts
Location
United States
Sponsor
The University of Texas Health
View Trial →
NCT05112601 Phase 2
Recruiting
Testing Nivolumab With or Without Ipilimumab in Deficient Mismatch Repair System...
Condition
Endometrial Adenocarcinoma
Enrollment
81 pts
Location
United States
Sponsor
National Cancer Institute (NCI
View Trial →
NCT05174169 Phase 2, Phase 3
Recruiting
Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease
Condition
Stage III Colon Cancer
Enrollment
1,912 pts
Location
United States, Canada, Puerto Rico
Sponsor
NRG Oncology
View Trial →
NCT05668741 Phase 1, Phase 2
Recruiting
A Phase 1/2 Study of VX-522 in Participants With Cystic Fibrosis (CF)
Condition
Cystic Fibrosis
Enrollment
39 pts
Location
United States, Australia, Belgium
Sponsor
Vertex Pharmaceuticals Incorpo
View Trial →
NCT05377372 N/A
Recruiting
Early Life Exposures Among Children With Sickle Cell Disease
Condition
Sickle Cell Disease
Enrollment
20 pts
Location
United States
Sponsor
University of Alabama at Birmi
View Trial →
NCT04485559 Phase 1
Recruiting
Trametinib and Everolimus for Treatment of Pediatric and Young Adult Patients Wi...
Condition
Recurrent World Health Organization (WHO) Grade II Glioma
Enrollment
50 pts
Location
United States
Sponsor
University of California, San
View Trial →
NCT05336201 Phase 2
Recruiting
Cognitive Remediation Intervention to Prepare for Transition of Care
Condition
Sickle Cell Disease
Enrollment
120 pts
Location
United States
Sponsor
University of Alabama at Birmi
View Trial →
NCT04929236 Phase 3
Recruiting
Study to Evaluate Safety and Efficacy of Different PANZYGA Dose Regimens in Pedi...
Condition
Pediatric Chronic Inflammatory Demyelinating Polyneuropathy
Enrollment
30 pts
Location
United States
Sponsor
Octapharma
View Trial →
NCT07061964 Phase 2
Recruiting
Combining Immunotherapy and Radiation Therapy to Help Patients Avoid Bladder Rem...
Condition
Muscle Invasive Bladder Urothelial Carcinoma
Enrollment
111 pts
Location
United States
Sponsor
National Cancer Institute (NCI
View Trial →
NCT06378632 N/A
Recruiting
AN INTERNATIONAL, OBSERVATIONAL, BLINDED STUDY TO ASSESS THE PERFORMANCE OF THE ...
Condition
Heart Failure
Enrollment
500 pts
Location
United States, Israel, Spain
Sponsor
Cordio Medical
View Trial →
NCT04284436 N/A
Recruiting
Study in Parkinson Disease of Exercise
Condition
Parkinson Disease
Enrollment
370 pts
Location
United States, Canada
Sponsor
Northwestern University
View Trial →
NCT04042844 Phase 2
Recruiting
A Single Dose of BRTX 100 for Patients With Chronic Lumbar Disc Disease (cLDD)
Condition
Lumbar Disc Disease
Enrollment
99 pts
Location
United States
Sponsor
BioRestorative Therapies
View Trial →
NCT04166409 Phase 3
Recruiting
A Study of the Drugs Selumetinib vs. Carboplatin and Vincristine in Patients Wit...
Condition
Low Grade Astrocytoma
Enrollment
170 pts
Location
United States, Canada, Puerto Rico
Sponsor
National Cancer Institute (NCI
View Trial →
NCT05606432 N/A
Recruiting
Cardiometabolic Health Intervention Using Movement-to-Music Exercise
Condition
Cardiometabolic Risk Factors in Adult Wheelchair Users
Enrollment
132 pts
Location
United States
Sponsor
University of Alabama at Birmi
View Trial →
NCT06637644 N/A
Recruiting
Impella RP Flex with Smart Assist
Condition
Right Ventricular (RV) Dysfunction
Enrollment
200 pts
Location
United States
Sponsor
Abiomed Inc.
View Trial →
NCT05126277 Phase 3
Recruiting
Safety, Efficacy and Tolerability of Ianalumab Versus Placebo, Combination With ...
Condition
Lupus Nephritis
Enrollment
462 pts
Location
United States, Argentina, Brazil
Sponsor
Novartis Pharmaceuticals
View Trial →
NCT06486428 N/A
Recruiting
Small Cell Lung Cancer Community Engagement to Eliminate Research Discepancies
Condition
Small-cell Lung Cancer
Enrollment
30 pts
Location
United States
Sponsor
Addario Lung Cancer Medical In
View Trial →
NCT06531863 EARLY_Phase 1
Recruiting
Curcumin and EGCG Supplementation to Improve Serum BDNF and Mood Disturbance
Condition
Mood Disturbance
Enrollment
64 pts
Location
United States
Sponsor
Auburn University
View Trial →
Page 5 of 8 — 178 trials total
← Prev Next →